Projects

RNDr. Vladimír Zelník, CSc.
Head of Biotechnology Laboratories Department

National

Current
  • Eradication of multiresistant microorganisms including carrier strains in patients using the personalised approach
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
Finished
  • Strengthening of research, development and innovation capacities of translational biomedical research of human diseases
    Program:
    Duration: 1. 1. 2020 – 30. 6. 2023
  • Improvement of the biotechnological research potential of the Biomedical Research Center of the Slovak Academy of Sciences to combat the pandemic COVID-19 in synergy with the European Virus Archive of Global Importance supported by the H2020 program
    Program:
    Duration: 1. 4. 2020 – 30. 6. 2023
  • Research of a barrier fabric for a community face half mask and protective clothing
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2023
  • Molecular immunerecognition of viral UL144 glycoprotein by endogenous signaling molecules and their clinical potential
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Imunomodulatory properties of the murine herpesvirus M3 protein and the role of ticks in herpesvirus circulation in nature
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • Activity Assay of Transfer Factor, Immunostimulatory Drug from Leukocytes Extract And Its Preparation Standardization
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • Preparation of erythropoietin a therapeutic hormone affecting the production of red blood cells by expression in eukaryotic cell system and its further purification
    Program: SRDA
    Duration: 1. 7. 2015 – 30. 6. 2019
  • Factors effecting production of cell-free Marek’s disease virus particles in vivo in chicken and in vitro in cell culture
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2017
  • -
    Program: EU Structural Funds Research & Development
    Duration: 1. 3. 2014 – 31. 12. 2015
  • Study on induced reactivation of human oncogenic herpesviruses on the model of mice latently infected with
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • Therapeutic potential of RNA interference and interferons against influenza virus infection
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • Effect of hypoxia on replication of herpesviruses.
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2013
Employees